167 related articles for article (PubMed ID: 9242545)
21. Control of HIV-1 Pathogenesis in Viremic Nonprogressors Is Independent of Gag-Specific Cytotoxic T Lymphocyte Responses.
Salgado M; Garcia-Minambres A; Dalmau J; Jiménez-Moyano E; Viciana P; Alejos B; Clotet B; Prado JG; Martinez-Picado J
J Virol; 2018 Jun; 92(12):. PubMed ID: 29593044
[TBL] [Abstract][Full Text] [Related]
22. Immunologic marker paths for seroconversion: single determinations of immunoglobulin A and beta 2-microglobulin are not adequate to estimate time of HIV infection. Multicohort Analysis Project Workshop. Part II.
AIDS; 1994 Jul; 8(7):923-33. PubMed ID: 7946101
[TBL] [Abstract][Full Text] [Related]
23. Neopterin and beta-2 microglobulin levels in asymptomatic HIV infection: the predictive value of combining markers.
Harrison NA; Skidmore SJ
J Med Virol; 1990 Oct; 32(2):128-33. PubMed ID: 2126281
[TBL] [Abstract][Full Text] [Related]
24. Correlation between plasma HIV-1 RNA levels and the rate of immunologic decline.
Iuliano R; Forastieri G; Brizzi M; Mecocci L; Mazzotta F; Ceccherini-Nelli L
J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Apr; 14(5):408-14. PubMed ID: 9170414
[TBL] [Abstract][Full Text] [Related]
25. Hemophilia and nonprogressing human immunodeficiency virus type 1 infection.
Vicenzi E; Bagnarelli P; Santagostino E; Ghezzi S; Alfano M; Sinnone MS; Fabio G; Turchetto L; Moretti G; Lazzarin A; Mantovani A; Mannucci PM; Clementi M; Gringeri A; Poli G
Blood; 1997 Jan; 89(1):191-200. PubMed ID: 8978292
[TBL] [Abstract][Full Text] [Related]
26. Spontaneous in vitro anti-human immunodeficiency virus type 1 antibody secretion by peripheral blood mononuclear cells is related to disease progression in zidovudine-treated adults.
Conge AM; Reynes J; Atoui N; Huguet MF; Ducos J; Bonardet A; Serre A; Vendrell JP
J Infect Dis; 1994 Dec; 170(6):1376-83. PubMed ID: 7995975
[TBL] [Abstract][Full Text] [Related]
27. Lack of in vitro anti-gp160 antibody production is a correlate of nonprogression among HIV type 1-infected individuals.
Rusconi S; Santambrogio S; Di Marco A; Colombo MC; Citterio P; Adorni F; Galli M
AIDS Res Hum Retroviruses; 1998 Oct; 14(15):1341-3. PubMed ID: 9788675
[TBL] [Abstract][Full Text] [Related]
28. Plasma viremia titration and RNA quantitation in ICD-p24 negative HIV type-1-infected patients.
Ercoli L; Sarmati L; el-Sawaf G; Cochi S; Lanti T; Iudicone P; Guglielmetti M; Giannini G; Galluzzo C; Tomino C
AIDS Res Hum Retroviruses; 1995 Oct; 11(10):1203-7. PubMed ID: 8573376
[TBL] [Abstract][Full Text] [Related]
29. Serum levels of soluble CD8, neopterin, beta 2-microglobulin and p24 antigen as indicators of disease progression in children with AIDS on zidovudine therapy.
Siller L; Martin NL; Kostuchenko P; Beckett L; Rautonen J; Cheng SC; Wara DW
AIDS; 1993 Mar; 7(3):369-73. PubMed ID: 8097095
[TBL] [Abstract][Full Text] [Related]
30. The predictive value of several markers in the progression to acquired immunodeficiency syndrome.
Planella T; Cortés M; Martínez-Brú C; Barrio J; Sambeat MA; González-Sastre F
Clin Chem Lab Med; 1998 Mar; 36(3):169-73. PubMed ID: 9589805
[TBL] [Abstract][Full Text] [Related]
31. Managing HIV. Part 4: Primary therapy. 4.3 The laboratory in managing HIV infection.
Dwyer DE; Adelstein S; Cunningham AL; Merigan TC
Med J Aust; 1996 Mar; 164(5):301-3. PubMed ID: 8628167
[TBL] [Abstract][Full Text] [Related]
32. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1.
Dis Markers; 1990; 8(3):164-5. PubMed ID: 2125538
[No Abstract] [Full Text] [Related]
33. Residual viraemia in HIV-1-infected patients with plasma viral load Ostrowski SR; Katzenstein TL; Pedersen BK; Gerstoft J; Ullum H
Scand J Immunol; 2008 Dec; 68(6):652-60. PubMed ID: 19055701
[TBL] [Abstract][Full Text] [Related]
34. The effect of high-dose saquinavir on viral load and CD4+ T-cell counts in HIV-infected patients.
Schapiro JM; Winters MA; Stewart F; Efron B; Norris J; Kozal MJ; Merigan TC
Ann Intern Med; 1996 Jun; 124(12):1039-50. PubMed ID: 8633817
[TBL] [Abstract][Full Text] [Related]
35. Natural history of HIV-1 cell-free viremia.
Henrard DR; Phillips JF; Muenz LR; Blattner WA; Wiesner D; Eyster ME; Goedert JJ
JAMA; 1995 Aug; 274(7):554-8. PubMed ID: 7629984
[TBL] [Abstract][Full Text] [Related]
36. Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts. Multicohort Analysis Project Workshop. Part I.
AIDS; 1994 Jul; 8(7):911-21. PubMed ID: 7946100
[TBL] [Abstract][Full Text] [Related]
37. Quantification of HIV-1 virus load under zidovudine therapy in patients with symptomatic HIV infection: relation to disease progression.
Molina JM; Ferchal F; Chevret S; Barateau V; Poirot C; Morinet F; Modai J
AIDS; 1994 Jan; 8(1):27-33. PubMed ID: 7912084
[TBL] [Abstract][Full Text] [Related]
38. Lack of predictive value for progression of dissociated circulating P24 antigen in human immunodeficiency virus type 1-infected black patients.
Prazuck T; Troisvallets D; Vallantin X; Patey O; Matta M; Fisch A; Lesguiller C; Si Mohammed A; Thomas M; Lafaix C; Bélec L
J Med Virol; 1996 Oct; 50(2):181-7. PubMed ID: 8915885
[TBL] [Abstract][Full Text] [Related]
39. 2',5'-oligoadenylate synthetase, neopterin and beta 2-microglobulin in asymptomatic HIV-infected individuals.
Witt PL; Spear GT; Lindstrom MJ; Kessler HA; Borden EC; Phair J; Landay AL
AIDS; 1991 Mar; 5(3):289-93. PubMed ID: 2059368
[TBL] [Abstract][Full Text] [Related]
40. CD4+:neopterin ratio correlates with p24 antigenaemia in HIV infected patients.
Crocchiolo PR; Lizioli A; Cantaluppi P; Filippi C; D'Agostino F; Cambié G; Panzeri MP; Nardella ML
J Clin Lab Immunol; 1990 Feb; 31(2):55-7. PubMed ID: 1983767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
